Article
For the past 25 years, the medical management of glaucoma has become increasingly successful. The medications currently available have superior tolerability and efficacy compared with the most commonly used drugs 20 years ago.
ARVO announces Swathi Kaliki, MD, as recipient of 2025 Ludwig von Sallmann Clinician-Scientist Award
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Survey reveals gaps in patient awareness of preservative-free glaucoma treatments
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension
Tenpoint Therapeutics Ltd. appoints Carol Kearney as Chief Commercial Officer